| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H16N2O5.O.Tc |
| Molecular Weight | 406.29 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[O--].[Tc+4].CC1=CC=CC(C)=C1NC(=O)CN(CC([O-])=O)CC([O-])=O
InChI
InChIKey=XHYOYWJTPCXJLF-UHFFFAOYSA-L
InChI=1S/C14H18N2O5.O.Tc/c1-9-4-3-5-10(2)14(9)15-11(17)6-16(7-12(18)19)8-13(20)21;;/h3-5H,6-8H2,1-2H3,(H,15,17)(H,18,19)(H,20,21);;/q;-2;+4/p-2
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
PubMed
Patents
ACTIVE MOIETY
SUBSTANCE RECORD
